Moorkens, E., Godman, B., Huys, I., Hoxha, I., Malaj, A., Keuerleber, S., . . . Vulto, A. G. (2021). The Expiry of Humira(®) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures. Front Pharmacol.
Citação norma ChicagoMoorkens, Evelien, et al. "The Expiry of Humira(®) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures." Front Pharmacol 2021.
ציטוט MLAMoorkens, Evelien, et al. "The Expiry of Humira(®) Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures." Front Pharmacol 2021.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.